AVITA Medical, Inc. (RCEL)
9.92
-0.14
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
9.92
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical 1 Year Total Returns (Daily) : 111.8% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 111.8% |
| August 20, 2026 | 115.1% |
| August 19, 2026 | 112.3% |
| August 18, 2026 | 77.48% |
| August 17, 2026 | 40.32% |
| August 14, 2026 | 35.34% |
| August 13, 2026 | 39.06% |
| August 12, 2026 | 47.10% |
| August 11, 2026 | 70.48% |
| August 10, 2026 | 78.82% |
| August 07, 2026 | 44.42% |
| August 06, 2026 | -11.38% |
| August 05, 2026 | -15.34% |
| August 04, 2026 | -13.46% |
| August 03, 2026 | -10.47% |
| July 31, 2026 | -16.98% |
| July 30, 2026 | -16.23% |
| July 29, 2026 | -22.78% |
| July 28, 2026 | -20.52% |
| July 27, 2026 | -17.68% |
| July 24, 2026 | -22.91% |
| July 23, 2026 | -26.36% |
| July 22, 2026 | -14.97% |
| July 21, 2026 | -2.30% |
| July 20, 2026 | -0.58% |
| Date | Value |
|---|---|
| July 17, 2026 | -6.08% |
| July 16, 2026 | -6.57% |
| July 15, 2026 | -11.59% |
| July 14, 2026 | -31.63% |
| July 13, 2026 | -30.70% |
| July 10, 2026 | -31.65% |
| July 09, 2026 | -21.67% |
| July 08, 2026 | -17.11% |
| July 07, 2026 | -3.29% |
| July 06, 2026 | -4.24% |
| July 02, 2026 | -2.13% |
| July 01, 2026 | -11.39% |
| June 30, 2026 | -21.93% |
| June 29, 2026 | -22.02% |
| June 26, 2026 | -22.46% |
| June 25, 2026 | -17.82% |
| June 24, 2026 | -20.04% |
| June 23, 2026 | -23.74% |
| June 22, 2026 | -22.05% |
| June 18, 2026 | -23.62% |
| June 17, 2026 | -24.38% |
| June 16, 2026 | -28.34% |
| June 15, 2026 | -29.06% |
| June 12, 2026 | -32.59% |
| June 11, 2026 | -34.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Halozyme Therapeutics, Inc. | 51.05% |
| Agenus, Inc. | 77.02% |
| Amgen, Inc. | 53.88% |
| Anika Therapeutics, Inc. | 140.7% |
| BioCryst Pharmaceuticals, Inc. | 13.96% |